An investigation into the effects of chronic infusion of corticotröphin-releasing factor on hind paw inflammation in adjuvant-induced arthritis

Stress

Volumn 1, Issue 2, 1996, Pages 105-111

  Harbuz, M S ^a,c   Chowdrey, H S ^a   Lightman, S L ^b   Vei, E T ^b   Jessop, D S ^b  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF GREENWICH   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ACTH; Adjuvant induced arthritis; CRF; Inflammation

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR;

ADJUVANT ARTHRITIS; ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS; THALAMUS MIDLINE NUCLEUS;

EID: 0030318308     PISSN: 10253890     EISSN: None     Source Type: Journal    
DOI: 10.3109/10253899609001100     Document Type: Article

References (32)

1. Basbaum, A. I. and Levine, J. D. (I990) The contribution of the nervous system to inflammation and inflammatory disease. Canadian Journal of Physiology and Pharmacology, 69, 647-651.
2. Carr, D. J., DeCosta, B., Jacobson, A., Rice, K. and Blalock, J. E. (1990) Corticotropin-releasing hormone augments natural killer cell activity through a naloxone-sensitive pathway. Journal of Neuroimmunology, 28, 53-61.
3. Chowdrey, H. S., Larsen, P. J., Harbuz, M. S., Jessop, D. S., Aguilera, G., Eckland, D. J. A. and Lightman, S. L. (1995) Evidence for arginine vasopressin as the primary activator of the HPA axis during adjuvant-induced arthritis. British Journal of Pharmacology (in press).
4. Crofford, L. J., Sano, H., Karalis, K., Friedman, T. C., Epps, H. R., Remmers, E. F., Mathem, P., Chrousos, G. P. and Wilder, R. L. (1993) Corticotrophin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis. Journal of Immunology, 151, 1587-1596.
5. Crofford, L. J., Sano, H., Karalis, K., Webster, E. L., Goldmuntz, E. A., Chrousos, G. P. and Wilder, R. L. (1992) Local secretion of corticotrophin-releasing hormone in the joints of Lewis rats with inflammatory arthritis. Journal of Clinical Investigation, 90, 2555-2564.
6. Cunnah, D., Jessop, D. S., Besser, G. M. & Rees, L. H. (1987) Measurement of circulating corticotrophin-releasing factor in man. Journal of Endocrinology, 113, 123-131.
7. Dunn, A. J. and Berridge, C. W. (1990) Physiological and behavioural responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Research Reviews, 15,71-100.-'
8. Harbuz, M. S. and Lightman, S. L. (1992) Stress and thé hypothalamo-pituitary-adrenal axis: acute, chronic and immunological activation. Journal of Endocrinology, 134, 327-339.
9. Harbuz, M. S., Rces, R. G., Eckland, D., Jessop, D. S., Brewerton, D. and Lightman, S. L. (1992) Paradoxical responses of hypothalamic CRF mRNA and CRF-41 peptide and adenohypophyseal POMC mRNA during chronic inflammatory stress. Endocrinology, 130, 1394-1400.
10. Hargreaves, K. M., Dubner, R. and Costelly, A. H. (1989) Corticotropin releasing factor (CRF) has a peripheral site of action for antinociception. European Journal of Pharmacology, 170, 275-279.
11. Irwin, M., Flauger, R. and Brown, M. (1992) Central corticotropinreleasing hormone activates the sympathetic nervous system and reduces immune function: increased responsivity of the aged rat. Endocrinology, 131, 1047-1053.
12. Irwin, M., Hauger, R., Jones, L., Provencio, M. and Britton, K. (1990) Sympathetic nervous system mediates central corticotropon-releasing factor induced suppression of natural killer cytotoxicity. Journal of Pharmacology and Experimental, Therapeutics, 255, 101-107.
13. Jessop, D. S., Eckland, D. J., Todd, K. and Lightman, S. L. (1989) Osmotic regulation of hypothalamo-neurointermediate lobe corticotrophin-releasing factor-41 in the rat. Journal of Endocrinology, 120,119-124.
14. Jessop, D. S., Renshaw, D., Lightman, S. L. and Harbuz, M. S. (1995) Changes in ACTH and -endorphin immunoreactivity in immune tissues during a chronic inflammatory stress are not correlated with changes in corticotropin-releasing hormone and arginine vasopressin. Journal ofNeuroimmunology, 60, 29-35.
15. Karalis, K., Sano, H., Redwine, J., Listwak, S., Wilder, R. L. and G. P., Chrousos. (1991) Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science, 254, 421-423.
16. Kavelaars, A., Ballieux, R. and Heijnen, C. (1989) The role of IL-1 in the corticotropin-releasing factor and arginine-vasopressininduced secretion of the immunoreactive b-endorphin by human peripheral blood mononuclear cells. Journal of Immunology, 142, 2338-2342.
17. Levine, J. D., Fields, H. L. and Basbaum, A. I. (1993) Peptides and the primary afferent nociceptor. Journal of Neuroscience, 13, 2273-2286.
18. Merchenthaler, I., Hynes, M. A., Vingh, S., Schally, A. V. and Petrusz, P. (1983) Immunocytochemical localization of corticotropin releasing factor (CRF) in the rat spinal cord. Brain Research, 275, 373-377.
19. Mousa, S. A., Mitchell, W. M., Hassan, A. H. S., Carter, L. and Stein, C. (1994) Corticotropin releasing factor receptors in inflamed tissue: Autoradiographic identification. Regulatory Peptides, 54, 203-204.
20. Owens, M. J. and Nemeroff, C. B. (1991) Physiology and pharmacology of corticotropin-rcleasing factor. Pharmacology Reviews, 43,425-473.
21. Przewlocki, R., Hassan, A. H. S., Lason, W., Epplen, C., Herz, A. and Stein, C. (1992) Gene expression and localization of opioid pcptides in immune cells of inflamed tissue: Functional role in anticociception. Nenroscience, 48,491-500.
22. Serda, S. M. and Wei, E. T. (1992) Epinephrinc-induced pulmonary oedema in rats is inhibited by corticotropin-releasing factor. Pharmacological Research, 26, 85-91.
23. Singh, V. (1989) Stimulatory effect of corticotropin-releasing neurohormonc on human lymphocyte proliferation and interIeukin-2 receptor expression. Journal ofNeuroimmunology, 23, 256-262.
24. Singh, V. and Leu, C. (1990) Enhancing effect of corticotropinreleasing'neurohormone on the production of interleukin-1 and interleukin-2. Neurosci. Lett., 120, 151-154.
25. Stephanou, A., Jessop, D. S., Knight, R. A. and Lightman, S. L. (1990) Corticotrophin-releasing factor-like immunoreactivity and mRNA in human leukocytes. Brain, Behaviour and Immunity, 4, 67-73.
26. Udelsman, R., Harwood, J. P., Millan, M. A., Chrousos, G. P., Goldstein, D. S., Zimlichman, R., Catt, K. J. and Aguilera, G. (1986) Functional corticotropin releasing factor receptors in the primate peripheral sympathetic nervous system. Nature, 319, 146-150.
27. Vale, W., Spiess, J., Rivier, C. and Rivier, J. (1981) Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and -endorphin. Science, 213, 1394-1397...
28. Vaughan, J., Donalson, C., Bittercourt, J. et al. (1995) Urocortin, a mammaliari;neuropeptide related to fish urocortin I and corticotrophin-releasing factor. Nature, 378, 287-292.
29. Wei, E. T. and Gao, G. C. (1991) Corticotropin-releasing factor: An inhibitor of vascular leakage in rat skeletal muscle and brain cortex after injury. Regulatory Peplides, 33, 93-104.
30. Wei, E. T. and Thomas, H. A. (1994) Correlation of neuroendocrine and anti-edema activities of alanine-corticotropin-releasing factor analogs. European Journal of Pharmacology, 263, 319-321.
31. Wei, E. T., Wong, J. C. and Kiang, J. G. (1990) Decreased inflammatory responsiveness of hypophysectomized rats to heat is reversed by a corticotropin-releasing factor (CRF) antagonist. Regulatory Peptides, 27, 317-323.
32. Williamson, S. A., Knight, R. A., Lightman, S. L. and Hobbs, J. R. (1988) Effects of -endorphin on specific immune responses in man. Immunology, 65,47-51.